Recombinant Human phhA Protein，His

The study of phhA recombinant protein focuses on the gene encoding phenylalanine hydroxylase, an enzyme crucial for the conversion of phenylalanine to tyrosine, an important amino acid for neurotransmitter synthesis. Abnormalities or deficiencies in this enzyme can lead to phenylketonuria (PKU), a metabolic disorder that can cause severe neurological damage if not managed properly. With the increasing prevalence of PKU and related metabolic disorders, understanding the structure, function, and mechanism of phhA becomes vital for developing effective diagnostic and therapeutic strategies. Research on phhA recombinant protein allows for the investigation of its enzymatic properties and potential applications in gene therapy, enzyme replacement strategies, and the design of inhibitors that could modulate its activity. Additionally, the recombinant form of the protein can be utilized in biochemical assays to elucidate its role in metabolic pathways and understand the consequences of its dysregulation in human health. By employing techniques such as molecular cloning, expression in suitable host systems, and characterization of the recombinant protein, researchers aim to garner insights into its biochemical function and its implications for treating metabolic diseases associated with phenylalanine metabolism. This area of research not only provides a deeper understanding of metabolic disorders like PKU but also sheds light on the potential for innovative therapeutic interventions that can improve patient outcomes in the future.